$405.840
-8.604 (-2.12%)收盘时
WAT 资讯
WAT 事件
Palantir Surges 15% After Earnings Beat Expectations
Stock futures are modestly higher as the market looks to build on Monday's rally, with technology shares continuing to lead gains ahead of another busy day of earnings. Technology remains the market's primary driver after another round of upbeat earnings reinforced optimism around artificial intelligence. Palantir surged after reporting results that exceeded expectations, helped by strong demand from government customers, while investors are now awaiting SpaceX's first quarterly earnings report since its June initial public offering.Geopolitical developments remain on investors' radar after another commercial vessel was struck near the Strait of Hormuz, highlighting continued risks to global shipping despite recent diplomatic efforts between the United States and Iran. Oil prices have rebounded modestly after Monday's sharp decline, though they remain well below last month's highs, easing some concerns about energy-driven inflation.Investors are also monitoring reports that the Trump administration is drafting restrictions on certain Chinese-made data center networking components over national security concerns, a move that could have implications for AI infrastructure and semiconductor supply chains.In pre-market trading, S&P 500 futures rose 0.35%, Nasdaq futures rose 1.12% and Dow futures rose 1.28%.Check out this morning's top movers from around Wall Street, compiled by The Fly.UP AFTER EARNINGS -Palantirup 15%Caterpillarup 11%Snapup 4%Archer Danielsup 3%Graphic Packagingup 3%Apollo Globalup 2%McDonald'sup 1%Toyotaup 1%Merckup 1%DOWN AFTER EARNINGS -Spotifydown 5%HSBCdown 2%Pinnacle Westdown 2%Wayfairdown 1%Watersdown 1%PagerDutydown 1%BPdown 1%
Company Sees Q3 Revenue of $1.75B-$1.6B
Sees Q3 revenue $1.75B-$1.6B, consensus $1.76B.
Waters Raises FY26 Revenue Outlook to $6.42B-$6.48B
Consensus $14.51. Raises FY26 revenue view to $6.42B-$6.48B from $6.41B-$6.46B, consensus $6.44B. Batra continued, "With momentum building across our portfolio, end markets, and synergies, we are raising every component of our full-year 2026 guidance. Looking ahead, as end market conditions continue to strengthen and our growth strategy compounds, Waters is better positioned today than at any point in our recent history, with a broader portfolio, a larger installed base, and the clearest set of growth catalysts we have ever had."
Waters Corporation Reports Q2 Revenue of $1.65B, Beating Expectations
Reports Q2 revenue $1.65B, consensus $1.62B. "Thanks to the hard work of our teams, we delivered industry-leading growth again this quarter, executing ahead of guidance across all four divisions," said Udit Batra, Ph.D., President & Chief Executive Officer, Waters Corporation. "Organic revenue grew 9% in constant currency, and our newly acquired businesses grew mid-single-digits in their first full quarter under Waters ownership. This performance reflects strong execution across the combined Company as our integration continues to gain momentum, while the recovery across our end markets has broadened with previously lagging customer segments now returning to growth."
IMU Biosciences Partners with Waters Corporation for AI Immunology Platform
IMU Biosciences and Waters Corporation announced a strategic partnership to accelerate the development of IMU's next-generation AI-powered High Definition Immunology platform. The partnership brings together Waters Biosciences' advanced flow cytometry and single-cell technologies, including BD FACSDiscover Cell Analyzers, BD flow cytometry reagents with BD Horizon Real Dyes, BD Rhapsody Instruments, and BD OMICS-One WTA Next Assay and Protein Panels, with IMU's HD analysis and proprietary AI and machine learning analytics, that can reproducibly characterize the immune system in real time, to turn complex immune data into insights at scale across discovery, translational, and clinical research applications.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。